In this activity, specialists in the MDT involved in caring for patients with dyslipidemia at high risk of ASCVD share their perspectives on novel lipid-lowering therapies and how the latest clinical data translate into clinical practice.
This activity is jointly provided by USF Health and touchIME.
This activity has been designed to meet the educational needs of cardiologists, endocrinologists and primary care physicians in Europe, UK and USA.
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. Relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
Prof. Lawrence Leiter discloses Research Support: Amgen, AstraZeneca, Bayer, Kowa, Lexicon, Novartis and The Medicines Company.
Advisory Board or Panel: Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Esperion, HLS, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi
Speakers Bureau: Amarin, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, HLS, Merck, Novartis, Novo Nordisk, Servier
Dr Yassir Javaid discloses Advisory Board or Panel: Novartis, Bayer, AstraZeneca, Daiichi Sankyo
Speakers Bureau: Abbott, Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, Edwards, Eli Lilly, iRhythm Technologies, Medtronic, Menarini, MSD, Novo Nordisk, Novartis, Pfizer, Sanofi and Servier.
Dr Constantine Kosmas discloses Speakers Bureau: Amarin Pharma, Inc., Amgen, Inc (Relationship terminated)
Madjid Mirzai-Tehrane, MD has no financial interests/relationships or affiliations in relation to this activity.
Touch Medical Director
Sola Neunie has no financial interests/relationships or affiliations in relation to this activity.
USF Health Office of Continuing Professional Development have no financial interests/relationships or affiliations in relation to this activity.
Requirements for Successful Completion
In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.
If you have questions regarding credit please contact email@example.com
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu)
Advanced Practice Providers
PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.
Date of original release: 12 August 2021. Date credits expire: 12 August 2022.
If you have any questions regarding credit please contact firstname.lastname@example.org